LEADER 03905nam  22006855  450 
001 9910373918003321
005 20220601190847.0
010   $a981-329-628-3
024 7 $a10.1007/978-981-32-9628-2
035   $a(CKB)4100000009837049
035   $a(DE-He213)978-981-32-9628-2
035   $a(MiAaPQ)EBC5976180
035   $a(PPN)260303909
035   $a(EXLCZ)994100000009837049
100   $a20191111d2019      u|             0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTherapeutic Vaccines as Novel Immunotherapy$b[electronic resource] $eBiological and Clinical Concepts /$fedited by Hironori Nakagami
205   $a1st ed. 2019.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2019.
215   $a1 online resource (VII, 79 p. 14 illus., 9 illus. in color.)
311   $a981-329-627-5 
320   $aIncludes bibliographical references.
327   $aChapter 1.Overview about the concept of therapeutic vaccine -- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease -- Chapter 3.Therapeutic vaccine for cardiovascular diseases -- Chapter 4.Immunotherapy for obesity -- Chapter 5.Immunotherapy for spondyloarthritis -- Chapter 6.Recent progress of DNA vaccine -- Chapter 7.Translational research of novel peptide vaccine -- Chapter 8.Conclusion.
330   $aThis book offers an excellent introduction to the use of novel therapeutic vaccines for common diseases based on their ability to induce antibody production. While the role of vaccines in the treatment of infectious diseases and cancer is well known, vaccines have also recently been developed for a variety of other conditions, including Alzheimer?s disease, hypertension, diabetes, and spondyloarthritis. These therapeutic advances are fully and clearly documented by acknowledged experts in the field, who explain the relevant biology and highlight the challenges involved in deploying this treatment approach effectively and safely. In addition, recent progress in the construction and delivery of DNA vaccines is documented, and the process of developing new peptide vaccines is explored in depth. While the book will be particularly valuable for researchers and scholars interested in immunotherapy, it will also appeal to clinicians seeking effective new medicines to treat patients suffering from chronic diseases.
606   $aImmunology
606   $aPharmaceutical technology
606   $aMedicine
606   $aVaccines
606   $aDrug resistance
606   $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000
606   $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010
606   $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007
606   $aVaccine$3https://scigraph.springernature.com/ontologies/product-market-codes/B16010
606   $aDrug Resistance$3https://scigraph.springernature.com/ontologies/product-market-codes/B16020
606   $aVacunes$2thub
608   $aLlibres electrònics$2thub
615  0$aImmunology.
615  0$aPharmaceutical technology.
615  0$aMedicine.
615  0$aVaccines.
615  0$aDrug resistance.
615 14$aImmunology.
615 24$aPharmaceutical Sciences/Technology.
615 24$aMedicine/Public Health, general.
615 24$aVaccine.
615 24$aDrug Resistance.
615  7$aVacunes
676   $a616.079
702   $aNakagami$b Hironori$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910373918003321
996   $aTherapeutic Vaccines as Novel Immunotherapy$92230342
997   $aUNINA